Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTongji Hospital
About this trial
This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female aged ≥18 years at the time of signing the informed consent form
Clinically or histologically confirmed diagnosis of liver cancer
Recieving treatment and follow-up in Tongji Hospital
Disqualifiers
None
Trial population
patients with liver cancer
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
liver resection
Procedure/SurgeryPatients undergo liver resection for tumor.
Systemic therapy combined with locoregional interventions
DrugPatients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions
Treatment groups
800 Participants
are divided into 2 treatment groupsGroup A: Liver resection group1 intervention
Group B: Non-surgery group1 intervention
Trial outcomes
Primary outcomes
1
overall survival
Time frame
From date of treatment until the date of death from any cause, assessed up to 100 monthsSecondary outcomes
1
Incidence of Adverse Events
Time frame
Within 30 days following interventionsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov